221 related articles for article (PubMed ID: 24351961)
1. Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures.
Sheeran PS; Matsunaga TO; Dayton PA
Phys Med Biol; 2014 Jan; 59(2):379-401. PubMed ID: 24351961
[TBL] [Abstract][Full Text] [Related]
2. Vaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validation.
Doinikov AA; Sheeran PS; Bouakaz A; Dayton PA
Med Phys; 2014 Oct; 41(10):102901. PubMed ID: 25281982
[TBL] [Abstract][Full Text] [Related]
3. Vaporization Detection Imaging: A Technique for Imaging Low-Boiling-Point Phase-Change Contrast Agents with a High Depth of Penetration and Contrast-to-Tissue Ratio.
Rojas JD; Dayton PA
Ultrasound Med Biol; 2019 Jan; 45(1):192-207. PubMed ID: 30482709
[TBL] [Abstract][Full Text] [Related]
4. Pulse sequences for uniform perfluorocarbon droplet vaporization and ultrasound imaging.
Puett C; Sheeran PS; Rojas JD; Dayton PA
Ultrasonics; 2014 Sep; 54(7):2024-33. PubMed ID: 24965563
[TBL] [Abstract][Full Text] [Related]
5. Thermal and Acoustic Stabilization Of Volatile Phase-Change Contrast Agents Via Layer-By-Layer Assembly.
Alcaraz PE; Davidson SJ; Shreeve E; Meuschke R; Romanowski M; Witte RS; Porter TR; Matsunaga TO
Ultrasound Med Biol; 2023 May; 49(5):1058-1069. PubMed ID: 36797095
[TBL] [Abstract][Full Text] [Related]
6. The efficiency and stability of bubble formation by acoustic vaporization of submicron perfluorocarbon droplets.
Reznik N; Shpak O; Gelderblom EC; Williams R; de Jong N; Versluis M; Burns PN
Ultrasonics; 2013 Sep; 53(7):1368-76. PubMed ID: 23652262
[TBL] [Abstract][Full Text] [Related]
7. On the acoustic properties of vaporized submicron perfluorocarbon droplets.
Reznik N; Lajoinie G; Shpak O; Gelderblom EC; Williams R; de Jong N; Versluis M; Burns PN
Ultrasound Med Biol; 2014 Jun; 40(6):1379-84. PubMed ID: 24462162
[TBL] [Abstract][Full Text] [Related]
8. Fluorous-phase iron oxide nanoparticles as enhancers of acoustic droplet vaporization of perfluorocarbons with supra-physiologic boiling point.
Vezeridis AM; de Gracia Lux C; Barnhill SA; Kim S; Wu Z; Jin S; Lux J; Gianneschi NC; Mattrey RF
J Control Release; 2019 May; 302():54-62. PubMed ID: 30928487
[TBL] [Abstract][Full Text] [Related]
9. Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review.
Rojas JD; Dayton PA
IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):264-272. PubMed ID: 27740481
[TBL] [Abstract][Full Text] [Related]
10. Effects of microchannel confinement on acoustic vaporisation of ultrasound phase change contrast agents.
Lin S; Zhang G; Leow CH; Tang MX
Phys Med Biol; 2017 Aug; 62(17):6884-6898. PubMed ID: 28718774
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous Nucleation of Stable Perfluorocarbon Emulsions for Ultrasound Contrast Agents.
Li DS; Schneewind S; Bruce M; Khaing Z; O'Donnell M; Pozzo L
Nano Lett; 2019 Jan; 19(1):173-181. PubMed ID: 30543289
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.
Sheeran PS; Rojas JD; Puett C; Hjelmquist J; Arena CB; Dayton PA
Ultrasound Med Biol; 2015 Mar; 41(3):814-31. PubMed ID: 25619781
[TBL] [Abstract][Full Text] [Related]
13. Preparation of perfluorocarbon emulsions by premix membrane emulsification for Acoustic Droplet Vaporization (ADV) in biomedical applications.
Melich R; Zorgani A; Padilla F; Charcosset C
Biomed Microdevices; 2020 Sep; 22(3):62. PubMed ID: 32880712
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Assessment of the Potential for Renal Bio-Effects from the Vaporization of Perfluorocarbon Phase-Change Contrast Agents.
Nyankima AG; Rojas JD; Cianciolo R; Johnson KA; Dayton PA
Ultrasound Med Biol; 2018 Feb; 44(2):368-376. PubMed ID: 29254872
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro.
Giesecke T; Hynynen K
Ultrasound Med Biol; 2003 Sep; 29(9):1359-65. PubMed ID: 14553814
[TBL] [Abstract][Full Text] [Related]
16. Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging.
Matsunaga TO; Sheeran PS; Luois S; Streeter JE; Mullin LB; Banerjee B; Dayton PA
Theranostics; 2012; 2(12):1185-98. PubMed ID: 23382775
[TBL] [Abstract][Full Text] [Related]
17. Repeated Acoustic Vaporization of Perfluorohexane Nanodroplets for Contrast-Enhanced Ultrasound Imaging.
Namen AV; Jandhyala S; Jordan T; Luke GP
IEEE Trans Ultrason Ferroelectr Freq Control; 2021 Dec; 68(12):3497-3506. PubMed ID: 34191726
[TBL] [Abstract][Full Text] [Related]
18. Quantifying activation of perfluorocarbon-based phase-change contrast agents using simultaneous acoustic and optical observation.
Li S; Lin S; Cheng Y; Matsunaga TO; Eckersley RJ; Tang MX
Ultrasound Med Biol; 2015 May; 41(5):1422-31. PubMed ID: 25656747
[TBL] [Abstract][Full Text] [Related]
19. Effects of droplet size and perfluorocarbon boiling point on the frequency dependence of acoustic vaporization threshold.
Aliabouzar M; Kumar KN; Sarkar K
J Acoust Soc Am; 2019 Feb; 145(2):1105. PubMed ID: 30823782
[TBL] [Abstract][Full Text] [Related]
20. Acoustic vaporization threshold of lipid-coated perfluoropentane droplets.
Aliabouzar M; Kumar KN; Sarkar K
J Acoust Soc Am; 2018 Apr; 143(4):2001. PubMed ID: 29716255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
